DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
MO-I430-BReP-F3-5 | To Establish Correlation Between Physical Microdosimetric Quantities Such as Dose Mean Lineal Energy, Target Size and Biological Endpoints Such as DNA Double Strand Breaks in HeLa Cells Irradiated with Iridium-192 High Dose Rate Brachytherapy Source and 225kV X-Rays S Dev1*, B Behmand2, P Pater3, S Abbasinejad Enger4, (1) McGill University, Montreal, QC, CA, (2) University of McGill, Montreal, QC, CA, (3) McGill University Health Centre, Montreal, QC, CA, (4) Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, CA |
TH-C-BRC-0 | Multi-Scale Modeling in Imaging and Therapy A Badal1*, X Jia2*, S Abbasinejad Enger3*, A McNamara4*, (1) U.S. Food & Drug Administration (CDRH/OSEL), Silver Spring, MD, (2) The University of Texas Southwestern Medical Ctr, Garland, TX, (3) Medical Physics Unit, McGill University, Montreal, QC, Canada, Montreal, QC, CA, (4) Harvard/MGH, Boston, MA |
TH-C-BRC-1 | Geometrical Models for Anatomical Phantoms and Their Use in X-Ray Imaging and Nuclear Medicine Simulations A Badal1*, X Jia2*, S Abbasinejad Enger3*, A McNamara4*, (1) U.S. Food & Drug Administration (CDRH/OSEL), Silver Spring, MD, (2) The University of Texas Southwestern Medical Ctr, Garland, TX, (3) Medical Physics Unit, McGill University, Montreal, QC, Canada, Montreal, QC, CA, (4) Harvard/MGH, Boston, MA |
TH-C-BRC-2 | Microdosimetric Simulations of Radiolysis and DNA Damage in X-Ray and Radiotherapy Applications A Badal1*, X Jia2*, S Abbasinejad Enger3*, A McNamara4*, (1) U.S. Food & Drug Administration (CDRH/OSEL), Silver Spring, MD, (2) The University of Texas Southwestern Medical Ctr, Garland, TX, (3) Medical Physics Unit, McGill University, Montreal, QC, Canada, Montreal, QC, CA, (4) Harvard/MGH, Boston, MA |
TH-C-BRC-3 | Modeling of Brachytherapy Treatments A Badal1*, X Jia2*, S Abbasinejad Enger3*, A McNamara4*, (1) U.S. Food & Drug Administration (CDRH/OSEL), Silver Spring, MD, (2) The University of Texas Southwestern Medical Ctr, Garland, TX, (3) Medical Physics Unit, McGill University, Montreal, QC, Canada, Montreal, QC, CA, (4) Harvard/MGH, Boston, MA |
TH-C-BRC-4 | Outcomes Modeling From Microscopic to Macroscopic Scales A Badal1*, X Jia2*, S Abbasinejad Enger3*, A McNamara4*, (1) U.S. Food & Drug Administration (CDRH/OSEL), Silver Spring, MD, (2) The University of Texas Southwestern Medical Ctr, Garland, TX, (3) Medical Physics Unit, McGill University, Montreal, QC, Canada, Montreal, QC, CA, (4) Harvard/MGH, Boston, MA |
TH-C-BRC-5 | Q & A A Badal1*, X Jia2*, S Abbasinejad Enger3*, A McNamara4*, (1) U.S. Food & Drug Administration (CDRH/OSEL), Silver Spring, MD, (2) The University of Texas Southwestern Medical Ctr, Garland, TX, (3) Medical Physics Unit, McGill University, Montreal, QC, Canada, Montreal, QC, CA, (4) Harvard/MGH, Boston, MA |
TU-D1030-IePD-F7-2 | Expanding Microdosimetry to Include Indirect Damage Induced by Protons and Alpha Particles A Bertolet*, G Tamborino, H Paganetti, J Schuemann, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA |
TU-J430-BReP-F3-2 | GPU-Accelerated Microdosimetry JM Decunha1,2*, R Mohan1, (1) Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas (2) Medical Physics Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas |
WE-B-BRC-2 | A Computational Multiscale Framework for Precision Dosimetry in Radiation Therapy P Inman*, J Houri, J Gounley, G Agasthya, A Kapadia, Oak Ridge National Laboratory, Oak Ridge, TN |